In particular, peripheral FAAH inhibition by URB937 increases the levels of AEA in trigeminal ganglia and reduces the trigeminal hyperalgesia induced by nitroglycerin (NTG) administration, used as an animal model of migraine [30]. Here, FAAH is linked to migraine disorder.